Drug-Device Combination Products Consultant in Hyderabad
Hyderabad, located in southern India, is home to a thriving medical device industry. The city is a hub for research and development, manufacturing, and export of medical devices. Many major players in the industry, as well as several smaller startups, are based in Hyderabad.
Combination products are a unique category of medical products that combine two or more regulated components, including drugs, devices, and biological products. As a Drug Device Combination Products Consultant in Hyderabad, we provide comprehensive guidance on combination products under 21 CFR 3.2 (e).
Types of Drug-Device Combination Products
- Pre-filled syringes
- Drug-eluting stents
- Inhalers
- Transdermal patches
- Implantable drug delivery systems
- Drug-device combination products for diagnostics
- Drug-device combination products for drug delivery systems
- Drug-device combination products for gene therapy
Drug-Device Combination Products Consultant in Hyderabad?
Let’s have word about your next project
Benefits of Drug-Drug Combination Products
Despite the challenges, drug-device combination products offer many unique benefits over traditional drugs or devices alone, such as targeted therapy, improved drug delivery, and increased patient compliance. They represent an exciting and growing area of innovation in the healthcare industry, with the potential to improve patient outcomes and quality of life.
If you are looking for expert guidance in the development and regulation of drug-device combination products in Hyderabad, Operon Strategist can help. Our team of experienced consultants offers a range of services. Contact us today to learn more.
FAQs
What is a drug-device combination product?
A drug-device combination product is a medical product that combines a drug, device, and/or biological component into a single integrated product, regulated under 21 CFR 3.2(e).
How are combination products regulated in the United States?
Combination products are regulated by the FDA based on their Primary Mode of Action (PMOA). The lead center (CDER, CDRH, or CBER) is assigned depending on whether the product acts primarily as a drug, device, or biologic.
What are examples of drug-device combination products?
Common examples include pre-filled syringes, drug-eluting stents, inhalers, transdermal patches, implantable drug delivery systems, and certain diagnostic combination products.
What regulatory challenges are involved in combination products?
Manufacturers must comply with both drug and device regulatory requirements, including quality systems, labeling regulations, clinical data, risk management, and post-market surveillance.
How can Operon Strategist help in Hyderabad?
Operon Strategist provides regulatory pathway assessment, PMOA determination, FDA submission strategy, technical documentation preparation, QMS integration, and end-to-end compliance support for drug-device combination products.